en.aazsante.fr
Anvisa approves new medicine for hepatitis C
The National Agency of Sanitary Surveillance (Anvisa) approved the registration of a new medicine for the treatment of Hepatitis C. The approval was published in the Official Gazette (DOU) , according to Anvisa, Maviret (glecaprevir / pibrentasvir) will be marketed in the form of a coated tablet with a concentration of 100mg and 40mg. The product is indicated for the treatment of Hepatitis C (genotypes 1, 2, 3, 4, 5 and 6) in patients with and without cirrhosis.
Maviret will be manufactured by Fournier Laboratories Ireland Ltd., and the holder of the drug registration in Brazil is Abbvie Farmacêutica Ltda.
How to treat Hepatitis C?
There is not always a need for treatment. The doctor will know if your case will require therapy or not. Usually, even for people who do not get treatment, follow-up blood tests are requested.
Other cases, however, will require treatment to avoid further complications. In these situations, hepatitis C infection is treated with a combination of antiviral drugs to be taken over several weeks, which aims to eliminate the virus from the patient's body.
Learn more about treatment for disease here!
Living with
If you have been diagnosed with hepatitis C, your doctor will probably recommend some lifestyle changes. These measures will help to keep you healthy, such as:
Stop drinking alcohol, which speeds up the progression of liver disease
- Avoid medications that can cause liver damage
- Prevent other people from contacting you his blood, covering the wounds and not sharing razors, manicure materials or toothbrushes. Do not give blood, organs or semen.
To date the drug has been tested on two patients and it is estimated that about 30 patients are waiting to be study in the next two years. For the first time, the vaccine was given in combination with small doses of chemotherapy to stimulate the immune system.
Sitting a lot of time can impair posture and cause back pain
Studies show that we spend seven hours a day sitting on average. The fact that we are seated for so long can cause or facilitate the occurrence of various problems, such as cardiovascular diseases, obesity, depression, early death and problems in the spine or other joints. Seated posture causes a lot of overload in the spine, especially the intervertebral disc, which can lead to its wear.